Amiodarone 5 mg/mL oral suspension
CGR-US-003 · Nationwide Children’s Hospital — Pharmacy Services, institutional compounding formula
INSTITUTIONAL SHEET — applies only to the exact described formula and requires local assessment.
Source formula
| Ingredient | Source quantity |
|---|---|
| Amiodarone 200 mg tablets | 5 δισκία / tablets |
| Sodium bicarbonate 50 mg/mL solution, to buffer vehicle | q.s. pH 6.5 ± 0.5 |
| Ora-Blend, buffered as described | q.s. ad 200 mL |
Quantities refer to the source batch. This website does not automatically scale formulas, assign doses or calculate BUD.
Description
Documented in sourceOpaque suspension.
References: [1]
Use and action
Documented in sourceAntiarrhythmic requiring substantial monitoring and interaction assessment.
Active-drug context from another product’s labelling; it does not establish stability or dosing of this compounded preparation.
References: [2]
Specifications
Documented in sourceBuffered vehicle: pH 6.5 ± 0.5. Check pH and final appearance.
References: [1]
Light
Partial evidenceFor the finished product the source specifies:
Tight, light-resistant container. Refrigerate; the stated 90 days applies under refrigeration.
References: [1]
Air
Not establishedNo specific information is established by the consulted sources. Complete this before local approval where critical to this preparation.
References: [1]
Water and solubility
Not establishedNo specific information is established by the consulted sources. Complete this before local approval where critical to this preparation.
References: [1]
Humidity
Partial evidenceProtect sodium bicarbonate from moisture.
References: [3]
Temperature
Partial evidenceHeating sodium bicarbonate can cause conversion to sodium carbonate, in solid material or solution.
References: [3]
pH and related incompatibilities
Partial evidenceSodium bicarbonate reacts with acids, releasing CO2.
Specification of this preparation, not a demonstrated stability range:
Buffered vehicle: pH 6.5 ± 0.5. Check pH and final appearance.
Other incompatibilities
Not establishedNo specific information is established by the consulted sources. Complete this before local approval where critical to this preparation.
References: [1]
Ingredient-specific information
Documented in sourceAdjust vehicle to pH 6.5 ± 0.5 with 50 mg/mL NaHCO3 to prevent clumping. The 3 g/60 mL prepares buffer stock; it is not necessarily all added.
References: [1]
Personal protective equipment
Partial evidenceComplete formula-specific PPE is not specified. Select gloves, eye protection and exposure controls using the exact materials’ SDS and the local risk assessment.
Supplementary AEMPS framework: clean long-sleeved laboratory clothing, hair covering and dedicated footwear/overshoes. Powder handling requires suitable eye/respiratory protection; change gloves with activity or damage. Select the exact type/material using SDS and risk assessment.
Risks and precautions
Partial evidenceA complete formula-specific hazard classification is not established. Assess potency, dust/aerosol, allergens, solvents, microbial risk and cross-contamination using the actual materials and process. Absence of a flag does not establish absence of hazard.
References: [1]
Compounding conditions
Partial evidenceFollow the addition sequence, temperatures and times stated under Preparation Procedure. The specific monograph is not a complete qualification of the local facility/equipment.
References: [1]
BUD rationale
Documented in sourceSource period: 90 days. Local BUD remains to be assessed.
The source period applies to its exact composition, method and packaging. It is not this batch’s expiry date and cannot be transferred to another vehicle/strength. Calculate the actual date in the blank batch record.
References: [1]
Bases and dependencies
Partial evidenceNo separate base is identified in the dependency register. Check any commercial vehicles/compound excipients listed in the formula.
References: [1]
Equipment
Editorial checklistIndicative checklist derived from the method: Balance of suitable resolution, Containers and mixing tools compatible with the materials, Mortar and pestle. Selection/qualification is defined locally.
References: [1]
Preparation procedure
Documented in sourcePrepare sodium bicarbonate 50 mg/mL (3 g, irrigation water to 60 mL). Buffer 200 mL Ora-Blend using portions of this stock. Triturate tablets, levigate and dilute geometrically with buffered vehicle to 200 mL. Let foam settle 10 minutes; recheck volume.
References: [1]
Observations
Documented in sourceThe 3 g/60 mL is a stock, not an instruction to add all of it. Source reports clumping without buffering.
References: [1]
Packaging
Documented in sourceTight light-resistant container.
References: [1]
Quality control
Documented in sourceVisual examination and pH measurement. Before incorporation, the vehicle must be pH 6.5 ± 0.5. Record final-product pH as well.
References: [1]
Storage
Documented in sourceTight, light-resistant container. Refrigerate; the stated 90 days applies under refrigeration.
References: [1]
Dispensing and directions
Partial evidenceNo additional special directions are established beyond the source route, storage and notes. Complete patient details, dose and directions from the prescription.
References: [1]
Labelling
editorial_specimenAmiodarone 5 mg/mL oral suspension
Strength/variant: __________ Quantity: __________
Batch: __________ Prepared: __________ Use by: __________
Από του στόματος / Oral use
Dose/directions: __________
Storage: Tight, light-resistant container. Refrigerate; the stated 90 days applies under refrigeration.
Shake before use.
References: [1]
Sources and traceability
- Nationwide Children’s Hospital — Pharmacy Services, institutional compounding formula
03/2025 · PDF pp. 1–2 · B2
Review date reported in supplied metadata: 2026-09-10
- DailyMed / NLM: AMIODARONE HYDROCHLORIDE TABLET [REMEDYREPACK INC.]
SPL published Aug 07, 2026 · Indications / warnings / pharmacology · C1 context only
Review date reported in supplied metadata: 2026-09-10
- FN/2003/PA/005 BICARBONATO DE SODIO
Διαθέσιμο κείμενο / Retrieved text · PDF pp. 1–2 · A1
Review date reported in supplied metadata: 2026-09-10
- PN/L/PG/002/00 INDUMENTARIA
Διαθέσιμο κείμενο / Retrieved text · PDF pp. 1–5 · A1
Review date reported in supplied metadata: 2026-09-10
Provenance and reuse
This record comes from the supplied v4 collection. Primary-source rights and licences remain separate. No new comprehensive licence review has been performed for the earlier 239 records.
SHA-256 of the supplied PDF: 26198d2838fba77a71c73fa09fc04d005ece5fb0c3cb7dac7c776ecbe1c8d42c